Skip to main content
. 2013 Feb 20;14(4):282–291.

Table 1.

Comparison of Royan bFGF with commercial bFGFs


Treatment Percent of human embryonic stem cell (hESC) grade A+B colonies.
P1 P2 P3 P4 Average

NTL 60(1:3) 70(1:2) 70(1:3) 65 <0.05
SML 60(1:3) 70(1:2) 60(1:3) 60
STML 70(1:4) 70(1:4) 70(1:4) 70 0.028
STMF 80(1:4) 80(1:4) 70(1:4) 75
Sigma bFGF 70(1:4) 70(1:4) 70(1:4) 70 0.566
Invitrogen bFGF 70(1:4) 60(1:4) 70(1:4) 65

All groups contain some treatment that the each treatment is shown in a capital letter S; Sonicated, N; Not sonicated, T; Tween 20, M: β-mercaptoethanol, L; Lyophilized and F; Fresh bFGF. NTL; Not treated with sonicator in the purification process. NTL contains Tween 20 in storage buffer and was lyophilized for long-term storage. STMF group: Treated with sonication, contained Tween 20 and β-mercaptoethanol in storage buffer and maintained at 4℃ without lyophilization. The percent of colonies that were grades A or B (A+B, see Fig 2) during each passage, P1-4: Passages 1-4, (1:n): Indicates proliferation rate during each passage. Clearly, the STMF group is the best group because it has highest percentage of undifferentiated cells and proliferation rate.